Follow
Robin B Brown
Robin B Brown
ABN / Guarantors of Brain Clinical Research Training Fellow, University of Cambridge
Verified email at cam.ac.uk - Homepage
Title
Cited by
Cited by
Year
Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta- analysis with implications for clinical trial design
R Brown, A Low, HS Markus
Journal of Neurology, Neurosurgery and Psychiatry, 2021
312021
Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease
S Nannoni, L Ohlmeier, RB Brown, RG Morris, AD MacKinnon, HS Markus, ...
International Journal of Stroke 17 (4), 415-424, 2022
292022
Do cerebral small vessel disease and multiple sclerosis share common mechanisms of white matter injury? A genetic study
RB Brown, M Traylor, S Burgess, S Sawcer, HS Markus
Stroke 50 (8), 1968-1972, 2019
162019
MINocyclinE to Reduce inflammation and blood brain barrier leakage in small Vessel diseAse (MINERVA) trial study protocol
RB Brown, DJ Tozer, L Loubière, YT Hong, TD Fryer, GB Williams, ...
European Stroke Journal 7 (3), 323-330, 2022
132022
Prevalence of, and risk factors for, cognitive impairment in lacunar stroke
L Ohlmeier, S Nannoni, C Pallucca, RB Brown, L Loubiere, HS Markus, ...
International Journal of Stroke 18 (1), 62-69, 2023
102023
Do regions of increased inflammation progress to new white matter hyperintensities?: A longitudinal positron emission tomography-magnetic resonance imaging study
DJ Tozer, RB Brown, J Walsh, YT Hong, GB Williams, JT O’Brien, ...
Stroke 54 (2), 549-557, 2023
42023
How often does white matter hyperintensity volume regress in cerebral small vessel disease?
RB Brown, DJ Tozer, M Egle, AM Tuladhar, FE de Leeuw, HS Markus
International Journal of Stroke 18 (8), 937-947, 2023
32023
Individual markers of cerebral small vessel disease and domain‐specific quality of life deficits
J Fernando, RB Brown, H Edwards, M Egle, HS Markus, J Tay
Brain and Behavior 11 (5), e02106, 2021
32021
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental …
RB Brown, DJ Tozer, L Loubière, EL Harshfield, YT Hong, TD Fryer, ...
Alzheimer's & Dementia, 2024
2024
Are central and systemic inflammation associated with fatigue in cerebral small vessel disease?
AA Jolly, RB Brown, DJ Tozer, YT Hong, TD Fryer, FI Aigbirhio, JT O’Brien, ...
International Journal of Stroke, 17474930241245613, 2024
2024
Disease mechanisms and markers of progression in cerebral small vessel disease
R Brown
2024
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol
B Rioux, M Chong, R Walker, S McGlasson, K Rannikmae, DL McCartney, ...
medRxiv, 2023.10. 12.23296935, 2023
2023
REGRESSION OF WHITE MATTER HYPERINTENSITY LESIONS IN CEREBRAL SMALL VESSEL DISEASE
R Brown, D Tozer, A Tuladhar, FE De Leeuw, HS Markus
INTERNATIONAL JOURNAL OF STROKE 16 (2_ SUPPL), 14-14, 2021
2021
COGNITIVE IMPACT OF CEREBRAL MICROBLEEDS IN PATIENTS WITH SYMPTOMATIC SMALL VESSEL DISEASE
S Nannoni, L Ohlmeier, L Loubiere, R Brown, E Harshfield, R Morris, ...
INTERNATIONAL JOURNAL OF STROKE 15 (1_ SUPPL), 36-36, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–14